Global VLP-based Vaccine Market Research Report 2024(Status and Outlook)
Report Overview:
Virus-like particles (VLPs) have evolved to become a widely accepted technology, especially in the field of vaccinology. In fact, some VLP-based vaccines are currently used as commercial medical products, and other VLP-based products are at different stages of clinical study. Several remarkable advantages have been achieved in the development of VLPs as gene therapy tools and new nanomaterials. In recent years, the technologies develop very fast that are used to characterize the structural integrity, stability, and components, including the encapsidated nucleic acids, of newly synthesized VLPs.
The Global VLP-based Vaccine Market Size was estimated at USD 580.21 million in 2023 and is projected to reach USD 941.37 million by 2029, exhibiting a CAGR of 8.40% during the forecast period.
This report provides a deep insight into the global VLP-based Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global VLP-based Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the VLP-based Vaccine market in any manner.
Global VLP-based Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Merck and Co.
GlaxoSmithKline
Pfizer
Dynavax Technologies
Sanofi
Wantai BioPharm
Serum Institute of India
Bharat Biotech
LG Chem
VBI Vaccines
Market Segmentation (by Type)
Live-Attenuated Vaccines
Inactivated Vaccines
Recombinant Vaccines
Toxoid Vaccines
Market Segmentation (by Application)
Hepatitis
HPV
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the VLP-based Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Virus-like particles (VLPs) have evolved to become a widely accepted technology, especially in the field of vaccinology. In fact, some VLP-based vaccines are currently used as commercial medical products, and other VLP-based products are at different stages of clinical study. Several remarkable advantages have been achieved in the development of VLPs as gene therapy tools and new nanomaterials. In recent years, the technologies develop very fast that are used to characterize the structural integrity, stability, and components, including the encapsidated nucleic acids, of newly synthesized VLPs.
The Global VLP-based Vaccine Market Size was estimated at USD 580.21 million in 2023 and is projected to reach USD 941.37 million by 2029, exhibiting a CAGR of 8.40% during the forecast period.
This report provides a deep insight into the global VLP-based Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global VLP-based Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the VLP-based Vaccine market in any manner.
Global VLP-based Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Merck and Co.
GlaxoSmithKline
Pfizer
Dynavax Technologies
Sanofi
Wantai BioPharm
Serum Institute of India
Bharat Biotech
LG Chem
VBI Vaccines
Market Segmentation (by Type)
Live-Attenuated Vaccines
Inactivated Vaccines
Recombinant Vaccines
Toxoid Vaccines
Market Segmentation (by Application)
Hepatitis
HPV
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the VLP-based Vaccine Market
- Overview of the regional outlook of the VLP-based Vaccine Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the VLP-based Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of VLP-based Vaccine
1.2 Key Market Segments
1.2.1 VLP-based Vaccine Segment by Type
1.2.2 VLP-based Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 VLP-BASED VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global VLP-based Vaccine Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global VLP-based Vaccine Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 VLP-BASED VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Global VLP-based Vaccine Sales by Manufacturers (2019-2024)
3.2 Global VLP-based Vaccine Revenue Market Share by Manufacturers (2019-2024)
3.3 VLP-based Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global VLP-based Vaccine Average Price by Manufacturers (2019-2024)
3.5 Manufacturers VLP-based Vaccine Sales Sites, Area Served, Product Type
3.6 VLP-based Vaccine Market Competitive Situation and Trends
3.6.1 VLP-based Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest VLP-based Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 VLP-BASED VACCINE INDUSTRY CHAIN ANALYSIS
4.1 VLP-based Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF VLP-BASED VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 VLP-BASED VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global VLP-based Vaccine Sales Market Share by Type (2019-2024)
6.3 Global VLP-based Vaccine Market Size Market Share by Type (2019-2024)
6.4 Global VLP-based Vaccine Price by Type (2019-2024)
7 VLP-BASED VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global VLP-based Vaccine Market Sales by Application (2019-2024)
7.3 Global VLP-based Vaccine Market Size (M USD) by Application (2019-2024)
7.4 Global VLP-based Vaccine Sales Growth Rate by Application (2019-2024)
8 VLP-BASED VACCINE MARKET SEGMENTATION BY REGION
8.1 Global VLP-based Vaccine Sales by Region
8.1.1 Global VLP-based Vaccine Sales by Region
8.1.2 Global VLP-based Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America VLP-based Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe VLP-based Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific VLP-based Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America VLP-based Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa VLP-based Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Merck and Co.
9.1.1 Merck and Co. VLP-based Vaccine Basic Information
9.1.2 Merck and Co. VLP-based Vaccine Product Overview
9.1.3 Merck and Co. VLP-based Vaccine Product Market Performance
9.1.4 Merck and Co. Business Overview
9.1.5 Merck and Co. VLP-based Vaccine SWOT Analysis
9.1.6 Merck and Co. Recent Developments
9.2 GlaxoSmithKline
9.2.1 GlaxoSmithKline VLP-based Vaccine Basic Information
9.2.2 GlaxoSmithKline VLP-based Vaccine Product Overview
9.2.3 GlaxoSmithKline VLP-based Vaccine Product Market Performance
9.2.4 GlaxoSmithKline Business Overview
9.2.5 GlaxoSmithKline VLP-based Vaccine SWOT Analysis
9.2.6 GlaxoSmithKline Recent Developments
9.3 Pfizer
9.3.1 Pfizer VLP-based Vaccine Basic Information
9.3.2 Pfizer VLP-based Vaccine Product Overview
9.3.3 Pfizer VLP-based Vaccine Product Market Performance
9.3.4 Pfizer VLP-based Vaccine SWOT Analysis
9.3.5 Pfizer Business Overview
9.3.6 Pfizer Recent Developments
9.4 Dynavax Technologies
9.4.1 Dynavax Technologies VLP-based Vaccine Basic Information
9.4.2 Dynavax Technologies VLP-based Vaccine Product Overview
9.4.3 Dynavax Technologies VLP-based Vaccine Product Market Performance
9.4.4 Dynavax Technologies Business Overview
9.4.5 Dynavax Technologies Recent Developments
9.5 Sanofi
9.5.1 Sanofi VLP-based Vaccine Basic Information
9.5.2 Sanofi VLP-based Vaccine Product Overview
9.5.3 Sanofi VLP-based Vaccine Product Market Performance
9.5.4 Sanofi Business Overview
9.5.5 Sanofi Recent Developments
9.6 Wantai BioPharm
9.6.1 Wantai BioPharm VLP-based Vaccine Basic Information
9.6.2 Wantai BioPharm VLP-based Vaccine Product Overview
9.6.3 Wantai BioPharm VLP-based Vaccine Product Market Performance
9.6.4 Wantai BioPharm Business Overview
9.6.5 Wantai BioPharm Recent Developments
9.7 Serum Institute of India
9.7.1 Serum Institute of India VLP-based Vaccine Basic Information
9.7.2 Serum Institute of India VLP-based Vaccine Product Overview
9.7.3 Serum Institute of India VLP-based Vaccine Product Market Performance
9.7.4 Serum Institute of India Business Overview
9.7.5 Serum Institute of India Recent Developments
9.8 Bharat Biotech
9.8.1 Bharat Biotech VLP-based Vaccine Basic Information
9.8.2 Bharat Biotech VLP-based Vaccine Product Overview
9.8.3 Bharat Biotech VLP-based Vaccine Product Market Performance
9.8.4 Bharat Biotech Business Overview
9.8.5 Bharat Biotech Recent Developments
9.9 LG Chem
9.9.1 LG Chem VLP-based Vaccine Basic Information
9.9.2 LG Chem VLP-based Vaccine Product Overview
9.9.3 LG Chem VLP-based Vaccine Product Market Performance
9.9.4 LG Chem Business Overview
9.9.5 LG Chem Recent Developments
9.10 VBI Vaccines
9.10.1 VBI Vaccines VLP-based Vaccine Basic Information
9.10.2 VBI Vaccines VLP-based Vaccine Product Overview
9.10.3 VBI Vaccines VLP-based Vaccine Product Market Performance
9.10.4 VBI Vaccines Business Overview
9.10.5 VBI Vaccines Recent Developments
10 VLP-BASED VACCINE MARKET FORECAST BY REGION
10.1 Global VLP-based Vaccine Market Size Forecast
10.2 Global VLP-based Vaccine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe VLP-based Vaccine Market Size Forecast by Country
10.2.3 Asia Pacific VLP-based Vaccine Market Size Forecast by Region
10.2.4 South America VLP-based Vaccine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of VLP-based Vaccine by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global VLP-based Vaccine Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of VLP-based Vaccine by Type (2025-2030)
11.1.2 Global VLP-based Vaccine Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of VLP-based Vaccine by Type (2025-2030)
11.2 Global VLP-based Vaccine Market Forecast by Application (2025-2030)
11.2.1 Global VLP-based Vaccine Sales (K Units) Forecast by Application
11.2.2 Global VLP-based Vaccine Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of VLP-based Vaccine
1.2 Key Market Segments
1.2.1 VLP-based Vaccine Segment by Type
1.2.2 VLP-based Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 VLP-BASED VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global VLP-based Vaccine Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global VLP-based Vaccine Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 VLP-BASED VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Global VLP-based Vaccine Sales by Manufacturers (2019-2024)
3.2 Global VLP-based Vaccine Revenue Market Share by Manufacturers (2019-2024)
3.3 VLP-based Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global VLP-based Vaccine Average Price by Manufacturers (2019-2024)
3.5 Manufacturers VLP-based Vaccine Sales Sites, Area Served, Product Type
3.6 VLP-based Vaccine Market Competitive Situation and Trends
3.6.1 VLP-based Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest VLP-based Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 VLP-BASED VACCINE INDUSTRY CHAIN ANALYSIS
4.1 VLP-based Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF VLP-BASED VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 VLP-BASED VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global VLP-based Vaccine Sales Market Share by Type (2019-2024)
6.3 Global VLP-based Vaccine Market Size Market Share by Type (2019-2024)
6.4 Global VLP-based Vaccine Price by Type (2019-2024)
7 VLP-BASED VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global VLP-based Vaccine Market Sales by Application (2019-2024)
7.3 Global VLP-based Vaccine Market Size (M USD) by Application (2019-2024)
7.4 Global VLP-based Vaccine Sales Growth Rate by Application (2019-2024)
8 VLP-BASED VACCINE MARKET SEGMENTATION BY REGION
8.1 Global VLP-based Vaccine Sales by Region
8.1.1 Global VLP-based Vaccine Sales by Region
8.1.2 Global VLP-based Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America VLP-based Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe VLP-based Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific VLP-based Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America VLP-based Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa VLP-based Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Merck and Co.
9.1.1 Merck and Co. VLP-based Vaccine Basic Information
9.1.2 Merck and Co. VLP-based Vaccine Product Overview
9.1.3 Merck and Co. VLP-based Vaccine Product Market Performance
9.1.4 Merck and Co. Business Overview
9.1.5 Merck and Co. VLP-based Vaccine SWOT Analysis
9.1.6 Merck and Co. Recent Developments
9.2 GlaxoSmithKline
9.2.1 GlaxoSmithKline VLP-based Vaccine Basic Information
9.2.2 GlaxoSmithKline VLP-based Vaccine Product Overview
9.2.3 GlaxoSmithKline VLP-based Vaccine Product Market Performance
9.2.4 GlaxoSmithKline Business Overview
9.2.5 GlaxoSmithKline VLP-based Vaccine SWOT Analysis
9.2.6 GlaxoSmithKline Recent Developments
9.3 Pfizer
9.3.1 Pfizer VLP-based Vaccine Basic Information
9.3.2 Pfizer VLP-based Vaccine Product Overview
9.3.3 Pfizer VLP-based Vaccine Product Market Performance
9.3.4 Pfizer VLP-based Vaccine SWOT Analysis
9.3.5 Pfizer Business Overview
9.3.6 Pfizer Recent Developments
9.4 Dynavax Technologies
9.4.1 Dynavax Technologies VLP-based Vaccine Basic Information
9.4.2 Dynavax Technologies VLP-based Vaccine Product Overview
9.4.3 Dynavax Technologies VLP-based Vaccine Product Market Performance
9.4.4 Dynavax Technologies Business Overview
9.4.5 Dynavax Technologies Recent Developments
9.5 Sanofi
9.5.1 Sanofi VLP-based Vaccine Basic Information
9.5.2 Sanofi VLP-based Vaccine Product Overview
9.5.3 Sanofi VLP-based Vaccine Product Market Performance
9.5.4 Sanofi Business Overview
9.5.5 Sanofi Recent Developments
9.6 Wantai BioPharm
9.6.1 Wantai BioPharm VLP-based Vaccine Basic Information
9.6.2 Wantai BioPharm VLP-based Vaccine Product Overview
9.6.3 Wantai BioPharm VLP-based Vaccine Product Market Performance
9.6.4 Wantai BioPharm Business Overview
9.6.5 Wantai BioPharm Recent Developments
9.7 Serum Institute of India
9.7.1 Serum Institute of India VLP-based Vaccine Basic Information
9.7.2 Serum Institute of India VLP-based Vaccine Product Overview
9.7.3 Serum Institute of India VLP-based Vaccine Product Market Performance
9.7.4 Serum Institute of India Business Overview
9.7.5 Serum Institute of India Recent Developments
9.8 Bharat Biotech
9.8.1 Bharat Biotech VLP-based Vaccine Basic Information
9.8.2 Bharat Biotech VLP-based Vaccine Product Overview
9.8.3 Bharat Biotech VLP-based Vaccine Product Market Performance
9.8.4 Bharat Biotech Business Overview
9.8.5 Bharat Biotech Recent Developments
9.9 LG Chem
9.9.1 LG Chem VLP-based Vaccine Basic Information
9.9.2 LG Chem VLP-based Vaccine Product Overview
9.9.3 LG Chem VLP-based Vaccine Product Market Performance
9.9.4 LG Chem Business Overview
9.9.5 LG Chem Recent Developments
9.10 VBI Vaccines
9.10.1 VBI Vaccines VLP-based Vaccine Basic Information
9.10.2 VBI Vaccines VLP-based Vaccine Product Overview
9.10.3 VBI Vaccines VLP-based Vaccine Product Market Performance
9.10.4 VBI Vaccines Business Overview
9.10.5 VBI Vaccines Recent Developments
10 VLP-BASED VACCINE MARKET FORECAST BY REGION
10.1 Global VLP-based Vaccine Market Size Forecast
10.2 Global VLP-based Vaccine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe VLP-based Vaccine Market Size Forecast by Country
10.2.3 Asia Pacific VLP-based Vaccine Market Size Forecast by Region
10.2.4 South America VLP-based Vaccine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of VLP-based Vaccine by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global VLP-based Vaccine Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of VLP-based Vaccine by Type (2025-2030)
11.1.2 Global VLP-based Vaccine Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of VLP-based Vaccine by Type (2025-2030)
11.2 Global VLP-based Vaccine Market Forecast by Application (2025-2030)
11.2.1 Global VLP-based Vaccine Sales (K Units) Forecast by Application
11.2.2 Global VLP-based Vaccine Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. VLP-based Vaccine Market Size Comparison by Region (M USD)
Table 5. Global VLP-based Vaccine Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global VLP-based Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 7. Global VLP-based Vaccine Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global VLP-based Vaccine Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in VLP-based Vaccine as of 2022)
Table 10. Global Market VLP-based Vaccine Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers VLP-based Vaccine Sales Sites and Area Served
Table 12. Manufacturers VLP-based Vaccine Product Type
Table 13. Global VLP-based Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of VLP-based Vaccine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. VLP-based Vaccine Market Challenges
Table 22. Global VLP-based Vaccine Sales by Type (K Units)
Table 23. Global VLP-based Vaccine Market Size by Type (M USD)
Table 24. Global VLP-based Vaccine Sales (K Units) by Type (2019-2024)
Table 25. Global VLP-based Vaccine Sales Market Share by Type (2019-2024)
Table 26. Global VLP-based Vaccine Market Size (M USD) by Type (2019-2024)
Table 27. Global VLP-based Vaccine Market Size Share by Type (2019-2024)
Table 28. Global VLP-based Vaccine Price (USD/Unit) by Type (2019-2024)
Table 29. Global VLP-based Vaccine Sales (K Units) by Application
Table 30. Global VLP-based Vaccine Market Size by Application
Table 31. Global VLP-based Vaccine Sales by Application (2019-2024) & (K Units)
Table 32. Global VLP-based Vaccine Sales Market Share by Application (2019-2024)
Table 33. Global VLP-based Vaccine Sales by Application (2019-2024) & (M USD)
Table 34. Global VLP-based Vaccine Market Share by Application (2019-2024)
Table 35. Global VLP-based Vaccine Sales Growth Rate by Application (2019-2024)
Table 36. Global VLP-based Vaccine Sales by Region (2019-2024) & (K Units)
Table 37. Global VLP-based Vaccine Sales Market Share by Region (2019-2024)
Table 38. North America VLP-based Vaccine Sales by Country (2019-2024) & (K Units)
Table 39. Europe VLP-based Vaccine Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific VLP-based Vaccine Sales by Region (2019-2024) & (K Units)
Table 41. South America VLP-based Vaccine Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa VLP-based Vaccine Sales by Region (2019-2024) & (K Units)
Table 43. Merck and Co. VLP-based Vaccine Basic Information
Table 44. Merck and Co. VLP-based Vaccine Product Overview
Table 45. Merck and Co. VLP-based Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Merck and Co. Business Overview
Table 47. Merck and Co. VLP-based Vaccine SWOT Analysis
Table 48. Merck and Co. Recent Developments
Table 49. GlaxoSmithKline VLP-based Vaccine Basic Information
Table 50. GlaxoSmithKline VLP-based Vaccine Product Overview
Table 51. GlaxoSmithKline VLP-based Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. GlaxoSmithKline Business Overview
Table 53. GlaxoSmithKline VLP-based Vaccine SWOT Analysis
Table 54. GlaxoSmithKline Recent Developments
Table 55. Pfizer VLP-based Vaccine Basic Information
Table 56. Pfizer VLP-based Vaccine Product Overview
Table 57. Pfizer VLP-based Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Pfizer VLP-based Vaccine SWOT Analysis
Table 59. Pfizer Business Overview
Table 60. Pfizer Recent Developments
Table 61. Dynavax Technologies VLP-based Vaccine Basic Information
Table 62. Dynavax Technologies VLP-based Vaccine Product Overview
Table 63. Dynavax Technologies VLP-based Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Dynavax Technologies Business Overview
Table 65. Dynavax Technologies Recent Developments
Table 66. Sanofi VLP-based Vaccine Basic Information
Table 67. Sanofi VLP-based Vaccine Product Overview
Table 68. Sanofi VLP-based Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Sanofi Business Overview
Table 70. Sanofi Recent Developments
Table 71. Wantai BioPharm VLP-based Vaccine Basic Information
Table 72. Wantai BioPharm VLP-based Vaccine Product Overview
Table 73. Wantai BioPharm VLP-based Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Wantai BioPharm Business Overview
Table 75. Wantai BioPharm Recent Developments
Table 76. Serum Institute of India VLP-based Vaccine Basic Information
Table 77. Serum Institute of India VLP-based Vaccine Product Overview
Table 78. Serum Institute of India VLP-based Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Serum Institute of India Business Overview
Table 80. Serum Institute of India Recent Developments
Table 81. Bharat Biotech VLP-based Vaccine Basic Information
Table 82. Bharat Biotech VLP-based Vaccine Product Overview
Table 83. Bharat Biotech VLP-based Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Bharat Biotech Business Overview
Table 85. Bharat Biotech Recent Developments
Table 86. LG Chem VLP-based Vaccine Basic Information
Table 87. LG Chem VLP-based Vaccine Product Overview
Table 88. LG Chem VLP-based Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. LG Chem Business Overview
Table 90. LG Chem Recent Developments
Table 91. VBI Vaccines VLP-based Vaccine Basic Information
Table 92. VBI Vaccines VLP-based Vaccine Product Overview
Table 93. VBI Vaccines VLP-based Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. VBI Vaccines Business Overview
Table 95. VBI Vaccines Recent Developments
Table 96. Global VLP-based Vaccine Sales Forecast by Region (2025-2030) & (K Units)
Table 97. Global VLP-based Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 98. North America VLP-based Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 99. North America VLP-based Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 100. Europe VLP-based Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 101. Europe VLP-based Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 102. Asia Pacific VLP-based Vaccine Sales Forecast by Region (2025-2030) & (K Units)
Table 103. Asia Pacific VLP-based Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 104. South America VLP-based Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 105. South America VLP-based Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 106. Middle East and Africa VLP-based Vaccine Consumption Forecast by Country (2025-2030) & (Units)
Table 107. Middle East and Africa VLP-based Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 108. Global VLP-based Vaccine Sales Forecast by Type (2025-2030) & (K Units)
Table 109. Global VLP-based Vaccine Market Size Forecast by Type (2025-2030) & (M USD)
Table 110. Global VLP-based Vaccine Price Forecast by Type (2025-2030) & (USD/Unit)
Table 111. Global VLP-based Vaccine Sales (K Units) Forecast by Application (2025-2030)
Table 112. Global VLP-based Vaccine Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. VLP-based Vaccine Market Size Comparison by Region (M USD)
Table 5. Global VLP-based Vaccine Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global VLP-based Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 7. Global VLP-based Vaccine Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global VLP-based Vaccine Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in VLP-based Vaccine as of 2022)
Table 10. Global Market VLP-based Vaccine Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers VLP-based Vaccine Sales Sites and Area Served
Table 12. Manufacturers VLP-based Vaccine Product Type
Table 13. Global VLP-based Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of VLP-based Vaccine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. VLP-based Vaccine Market Challenges
Table 22. Global VLP-based Vaccine Sales by Type (K Units)
Table 23. Global VLP-based Vaccine Market Size by Type (M USD)
Table 24. Global VLP-based Vaccine Sales (K Units) by Type (2019-2024)
Table 25. Global VLP-based Vaccine Sales Market Share by Type (2019-2024)
Table 26. Global VLP-based Vaccine Market Size (M USD) by Type (2019-2024)
Table 27. Global VLP-based Vaccine Market Size Share by Type (2019-2024)
Table 28. Global VLP-based Vaccine Price (USD/Unit) by Type (2019-2024)
Table 29. Global VLP-based Vaccine Sales (K Units) by Application
Table 30. Global VLP-based Vaccine Market Size by Application
Table 31. Global VLP-based Vaccine Sales by Application (2019-2024) & (K Units)
Table 32. Global VLP-based Vaccine Sales Market Share by Application (2019-2024)
Table 33. Global VLP-based Vaccine Sales by Application (2019-2024) & (M USD)
Table 34. Global VLP-based Vaccine Market Share by Application (2019-2024)
Table 35. Global VLP-based Vaccine Sales Growth Rate by Application (2019-2024)
Table 36. Global VLP-based Vaccine Sales by Region (2019-2024) & (K Units)
Table 37. Global VLP-based Vaccine Sales Market Share by Region (2019-2024)
Table 38. North America VLP-based Vaccine Sales by Country (2019-2024) & (K Units)
Table 39. Europe VLP-based Vaccine Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific VLP-based Vaccine Sales by Region (2019-2024) & (K Units)
Table 41. South America VLP-based Vaccine Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa VLP-based Vaccine Sales by Region (2019-2024) & (K Units)
Table 43. Merck and Co. VLP-based Vaccine Basic Information
Table 44. Merck and Co. VLP-based Vaccine Product Overview
Table 45. Merck and Co. VLP-based Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Merck and Co. Business Overview
Table 47. Merck and Co. VLP-based Vaccine SWOT Analysis
Table 48. Merck and Co. Recent Developments
Table 49. GlaxoSmithKline VLP-based Vaccine Basic Information
Table 50. GlaxoSmithKline VLP-based Vaccine Product Overview
Table 51. GlaxoSmithKline VLP-based Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. GlaxoSmithKline Business Overview
Table 53. GlaxoSmithKline VLP-based Vaccine SWOT Analysis
Table 54. GlaxoSmithKline Recent Developments
Table 55. Pfizer VLP-based Vaccine Basic Information
Table 56. Pfizer VLP-based Vaccine Product Overview
Table 57. Pfizer VLP-based Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Pfizer VLP-based Vaccine SWOT Analysis
Table 59. Pfizer Business Overview
Table 60. Pfizer Recent Developments
Table 61. Dynavax Technologies VLP-based Vaccine Basic Information
Table 62. Dynavax Technologies VLP-based Vaccine Product Overview
Table 63. Dynavax Technologies VLP-based Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Dynavax Technologies Business Overview
Table 65. Dynavax Technologies Recent Developments
Table 66. Sanofi VLP-based Vaccine Basic Information
Table 67. Sanofi VLP-based Vaccine Product Overview
Table 68. Sanofi VLP-based Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Sanofi Business Overview
Table 70. Sanofi Recent Developments
Table 71. Wantai BioPharm VLP-based Vaccine Basic Information
Table 72. Wantai BioPharm VLP-based Vaccine Product Overview
Table 73. Wantai BioPharm VLP-based Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Wantai BioPharm Business Overview
Table 75. Wantai BioPharm Recent Developments
Table 76. Serum Institute of India VLP-based Vaccine Basic Information
Table 77. Serum Institute of India VLP-based Vaccine Product Overview
Table 78. Serum Institute of India VLP-based Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Serum Institute of India Business Overview
Table 80. Serum Institute of India Recent Developments
Table 81. Bharat Biotech VLP-based Vaccine Basic Information
Table 82. Bharat Biotech VLP-based Vaccine Product Overview
Table 83. Bharat Biotech VLP-based Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Bharat Biotech Business Overview
Table 85. Bharat Biotech Recent Developments
Table 86. LG Chem VLP-based Vaccine Basic Information
Table 87. LG Chem VLP-based Vaccine Product Overview
Table 88. LG Chem VLP-based Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. LG Chem Business Overview
Table 90. LG Chem Recent Developments
Table 91. VBI Vaccines VLP-based Vaccine Basic Information
Table 92. VBI Vaccines VLP-based Vaccine Product Overview
Table 93. VBI Vaccines VLP-based Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. VBI Vaccines Business Overview
Table 95. VBI Vaccines Recent Developments
Table 96. Global VLP-based Vaccine Sales Forecast by Region (2025-2030) & (K Units)
Table 97. Global VLP-based Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 98. North America VLP-based Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 99. North America VLP-based Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 100. Europe VLP-based Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 101. Europe VLP-based Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 102. Asia Pacific VLP-based Vaccine Sales Forecast by Region (2025-2030) & (K Units)
Table 103. Asia Pacific VLP-based Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 104. South America VLP-based Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 105. South America VLP-based Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 106. Middle East and Africa VLP-based Vaccine Consumption Forecast by Country (2025-2030) & (Units)
Table 107. Middle East and Africa VLP-based Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 108. Global VLP-based Vaccine Sales Forecast by Type (2025-2030) & (K Units)
Table 109. Global VLP-based Vaccine Market Size Forecast by Type (2025-2030) & (M USD)
Table 110. Global VLP-based Vaccine Price Forecast by Type (2025-2030) & (USD/Unit)
Table 111. Global VLP-based Vaccine Sales (K Units) Forecast by Application (2025-2030)
Table 112. Global VLP-based Vaccine Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of VLP-based Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global VLP-based Vaccine Market Size (M USD), 2019-2030
Figure 5. Global VLP-based Vaccine Market Size (M USD) (2019-2030)
Figure 6. Global VLP-based Vaccine Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. VLP-based Vaccine Market Size by Country (M USD)
Figure 11. VLP-based Vaccine Sales Share by Manufacturers in 2023
Figure 12. Global VLP-based Vaccine Revenue Share by Manufacturers in 2023
Figure 13. VLP-based Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market VLP-based Vaccine Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by VLP-based Vaccine Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global VLP-based Vaccine Market Share by Type
Figure 18. Sales Market Share of VLP-based Vaccine by Type (2019-2024)
Figure 19. Sales Market Share of VLP-based Vaccine by Type in 2023
Figure 20. Market Size Share of VLP-based Vaccine by Type (2019-2024)
Figure 21. Market Size Market Share of VLP-based Vaccine by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global VLP-based Vaccine Market Share by Application
Figure 24. Global VLP-based Vaccine Sales Market Share by Application (2019-2024)
Figure 25. Global VLP-based Vaccine Sales Market Share by Application in 2023
Figure 26. Global VLP-based Vaccine Market Share by Application (2019-2024)
Figure 27. Global VLP-based Vaccine Market Share by Application in 2023
Figure 28. Global VLP-based Vaccine Sales Growth Rate by Application (2019-2024)
Figure 29. Global VLP-based Vaccine Sales Market Share by Region (2019-2024)
Figure 30. North America VLP-based Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America VLP-based Vaccine Sales Market Share by Country in 2023
Figure 32. U.S. VLP-based Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada VLP-based Vaccine Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico VLP-based Vaccine Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe VLP-based Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe VLP-based Vaccine Sales Market Share by Country in 2023
Figure 37. Germany VLP-based Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France VLP-based Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. VLP-based Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy VLP-based Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia VLP-based Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific VLP-based Vaccine Sales and Growth Rate (K Units)
Figure 43. Asia Pacific VLP-based Vaccine Sales Market Share by Region in 2023
Figure 44. China VLP-based Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan VLP-based Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea VLP-based Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India VLP-based Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia VLP-based Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America VLP-based Vaccine Sales and Growth Rate (K Units)
Figure 50. South America VLP-based Vaccine Sales Market Share by Country in 2023
Figure 51. Brazil VLP-based Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina VLP-based Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia VLP-based Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa VLP-based Vaccine Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa VLP-based Vaccine Sales Market Share by Region in 2023
Figure 56. Saudi Arabia VLP-based Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE VLP-based Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt VLP-based Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria VLP-based Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa VLP-based Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global VLP-based Vaccine Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global VLP-based Vaccine Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global VLP-based Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global VLP-based Vaccine Market Share Forecast by Type (2025-2030)
Figure 65. Global VLP-based Vaccine Sales Forecast by Application (2025-2030)
Figure 66. Global VLP-based Vaccine Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of VLP-based Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global VLP-based Vaccine Market Size (M USD), 2019-2030
Figure 5. Global VLP-based Vaccine Market Size (M USD) (2019-2030)
Figure 6. Global VLP-based Vaccine Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. VLP-based Vaccine Market Size by Country (M USD)
Figure 11. VLP-based Vaccine Sales Share by Manufacturers in 2023
Figure 12. Global VLP-based Vaccine Revenue Share by Manufacturers in 2023
Figure 13. VLP-based Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market VLP-based Vaccine Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by VLP-based Vaccine Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global VLP-based Vaccine Market Share by Type
Figure 18. Sales Market Share of VLP-based Vaccine by Type (2019-2024)
Figure 19. Sales Market Share of VLP-based Vaccine by Type in 2023
Figure 20. Market Size Share of VLP-based Vaccine by Type (2019-2024)
Figure 21. Market Size Market Share of VLP-based Vaccine by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global VLP-based Vaccine Market Share by Application
Figure 24. Global VLP-based Vaccine Sales Market Share by Application (2019-2024)
Figure 25. Global VLP-based Vaccine Sales Market Share by Application in 2023
Figure 26. Global VLP-based Vaccine Market Share by Application (2019-2024)
Figure 27. Global VLP-based Vaccine Market Share by Application in 2023
Figure 28. Global VLP-based Vaccine Sales Growth Rate by Application (2019-2024)
Figure 29. Global VLP-based Vaccine Sales Market Share by Region (2019-2024)
Figure 30. North America VLP-based Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America VLP-based Vaccine Sales Market Share by Country in 2023
Figure 32. U.S. VLP-based Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada VLP-based Vaccine Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico VLP-based Vaccine Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe VLP-based Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe VLP-based Vaccine Sales Market Share by Country in 2023
Figure 37. Germany VLP-based Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France VLP-based Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. VLP-based Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy VLP-based Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia VLP-based Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific VLP-based Vaccine Sales and Growth Rate (K Units)
Figure 43. Asia Pacific VLP-based Vaccine Sales Market Share by Region in 2023
Figure 44. China VLP-based Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan VLP-based Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea VLP-based Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India VLP-based Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia VLP-based Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America VLP-based Vaccine Sales and Growth Rate (K Units)
Figure 50. South America VLP-based Vaccine Sales Market Share by Country in 2023
Figure 51. Brazil VLP-based Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina VLP-based Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia VLP-based Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa VLP-based Vaccine Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa VLP-based Vaccine Sales Market Share by Region in 2023
Figure 56. Saudi Arabia VLP-based Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE VLP-based Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt VLP-based Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria VLP-based Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa VLP-based Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global VLP-based Vaccine Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global VLP-based Vaccine Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global VLP-based Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global VLP-based Vaccine Market Share Forecast by Type (2025-2030)
Figure 65. Global VLP-based Vaccine Sales Forecast by Application (2025-2030)
Figure 66. Global VLP-based Vaccine Market Share Forecast by Application (2025-2030)
